Kael Pharmacysp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-10-18
Share capital
5,000.00 PLN
Registered address
Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 68 days for 2021).

  • 202510/07/2026
  • 202416/07/2025
  • 202309/07/2024
  • 202228/08/2023
  • 202121/09/2022
  • 202014/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Dispensing chemist in specialised stores603 / 1,512
Top 40%
Division · Retail trade2,747 / 9,915
Top 28%
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles8,166 / 29,903
Top 27%
City · Warszawa7,880 / 56,967
Top 14%
Voivodeship · Mazowieckie11,210 / 77,130
Top 15%
Country · Poland43,259 / 297,932
Top 15%

Results vs industry

Revenue
This companyUSD 3.43mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 31.42kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 3.33mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.12mMedianUSD 543.65kAverageUSD 1.76m

Industry

Public procurement

Kael Pharmacy is the contractor in one public sector contract, worth USD 216.12.

SubjectAmount
Pharmaceutical materials for teaching activities in the Nursing programme
$216.12

National Health Fund (NFZ) contracts

Kael Pharmacy has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 283.63. All its contracts were worth USD 2.11k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmespodlaskie1USD 283.63
Other services provided in pharmaciespodlaskie1USD 0.00

Authorized Representatives

Grzegorz Bajtałaage 51 – President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action of two members of the management board, or one member of the management board together with a commercial proxy, is required to make declarations on behalf of the company. If the management board is a one-person management board, the President of the Management Board represents the company independently.

Ownership

OwnerSharesShare valueStake
Megafarm sp. z o.o.
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-01-08.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 6,217

Public aid

4 public aid cases recorded, with a total value of $13,218.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Modrzewscysp. j.
Adpharmasp. z o.o.
Ms-Pharmsp. z o.o. + limited partnership
MagmaxS.A.
Farmjug Agsp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.

Change history

DateEvent
2026-09-26PKD change
2023-12-05Address change
2023-12-05PKD change
2018-11-16Address change
2018-04-27Address change

FAQ

Last updated: 2026-10-07